GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, 2904
N. diseases: 249; N. variants: 83
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 12 | 13822364 | intron variant | G/A | snv | 0.39 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 12 | 13716791 | intron variant | G/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
12 | 13719110 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
12 | 13787914 | intron variant | T/C | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 12 | 13713238 | intron variant | C/T | snv | 0.34 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 12 | 13713238 | intron variant | C/T | snv | 0.34 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 12 | 13713238 | intron variant | C/T | snv | 0.34 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 12 | 13713238 | intron variant | C/T | snv | 0.34 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
12 | 13708056 | intron variant | G/A | snv | 7.4E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
12 | 13774962 | intron variant | C/A;T | snv |
|
0.800 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1.000 | 0.040 | 12 | 13970151 | intron variant | C/T | snv | 0.80 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 12 | 13452306 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 12 | 13456506 | intron variant | T/C | snv | 0.90 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 12 | 13879926 | intron variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 12 | 13454884 | intron variant | C/G | snv | 0.65 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 12 | 13567084 | stop gained | G/A | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.925 | 12 | 13567084 | stop gained | G/A | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 12 | 13608792 | stop gained | C/G;T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13608647 | stop gained | G/A | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13611828 | stop gained | C/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13571888 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 18 | 2007 | 2017 | |||||||||
|
0.807 | 0.160 | 12 | 13567164 | missense variant | C/A;G;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 18 | 2007 | 2017 | |||||||
|
1.000 | 12 | 13571888 | missense variant | C/T | snv |
|
0.800 | 1.000 | 7 | 2010 | 2017 | ||||||||||
|
1.000 | 12 | 13571931 | missense variant | G/A | snv |
|
0.800 | 1.000 | 7 | 2010 | 2017 | ||||||||||
|
1.000 | 12 | 13615626 | missense variant | C/T | snv |
|
0.800 | 1.000 | 7 | 2010 | 2017 |